Alex Zevin, PhD, of @fredhutch put Countable PCR to work across 9 labs: linear response over 6 orders of magnitude and fusion detection from 55 pg of RNA.
~30M compartments. Every molecule counted directly.
Via @genbio: na2.hubs.ly/H08r4DD0
#PCR #Genomics #CountablePCR
countablelabs retweeted
Unlock the power of digital PCR! Join our free GEN webinar on June 18 to explore applications and challenges in research and clinical labs. Register now: hubs.li/Q04gDlQ10 #PCR #Genomics #ClinicalLabs
countablelabs retweeted
🗓️ Today’s the last day to register for #AMP2026 at the standard registration rate. Register by 11:59 p.m. Eastern to save.
Don’t wait until it’s too late!
Register: ow.ly/WwAW50ZVvY3
Join us at the @DrugDiscovNews Live Symposium, Nov 17–18, where Samir Afif, PhD, will share how Countable #PCR's single-molecule analysis reveals what titer can miss.
Register: na2.hubs.ly/H08r4CY0
Also speaking: experts from @Stanford, @biotechne, @UCSanDiego, and more.
Meet Countable Labs at #AMP2026! 🔬
Discover single-molecule #PCR for BCR::ABL1, KMT2A, NPM1 & methylation at Booth #943.
📊 4 posters
🤝 Live demos
🎤 Workshop with @fredhutch, @UTMDAnderson & HematoLogics
Learn more: na2.hubs.ly/H08r4zS0
@AMPath
What's next for #PCR?
Join Wim Trypsteen, PhD, and Gordon Janaway, PhD, on Oct. 28 for a @GenomeWeb webinar exploring #dPCR reproducibility, standardization, and next-gen PCR with direct #singlemoleculecounting across 30M+ compartments.
Register now: na2.hubs.ly/H08kgzr0
Looking forward to #AMP2026!
Engage with our advocacy experts and other professionals working to address critical challenges in the field of molecular pathology by joining us at #AMP2026 in Seattle, Nov. 10–14.
Be a part of the change you want to see. Register: ow.ly/BK6850ZVvTq
Broad coverage or deep sensitivity? In #leukemiatesting, you shouldn't have to choose.
Our on-demand workshop shows how single-molecule counting delivers both. na2.hubs.ly/H08hRVq0
#PCR #MRD
Can leukemia testing deliver both broad coverage and deep MRD sensitivity? Watch this on-demand corporate workshop from @countablelabs to explore how single-molecule counting assays can help overcome this trade-off.
player.vimeo.com/video/12310…
Meet Ancora, our first clinical research assays for heme oncology, built on Countable PCR.
Sensitive to residual disease. Tighter CVs than conventional RT-PCR. Multiplexed, high-throughput, low input.
Don’t just take our word for it ⬇️
Explore Ancora: na2.hubs.ly/H08kgf40
🧬 New research in @MolTherapy highlights Countable PCR in the characterization of residual plasmid and host-cell DNA in AAV vectors.
Congratulations to Mojca Janc and David Dobnik on the publication!
Read the paper: na2.hubs.ly/H08hGLf0
#GeneTherapy #CountablePCR
Missed our webinar with @AMPath? Catch it on demand: single-molecule counting PCR for MRD in CML and AML, no standard curves required.
Watch now: na2.hubs.ly/H08hRVq0
#MRD #HemeOnc
One color doesn't have to mean one target.
Countable PCR combines chemistries into unique optical signatures, so targets can outnumber color channels.
HPV: multiple subtypes, one reaction
KMT2A: 18 fusions across 6 partners, one assay
More targets. More from every sample.
🎙️ What happens when you stop estimating and start counting?
Our founder and CTO, Christina Fan, PhD, spoke with Technology Networks about how Countable PCR is advancing quantitative molecular analysis.
Read the interview 👉 na2.hubs.ly/H08fr440
#CellAndGeneTherapy
Early detection remains one of the most effective tools against breast cancer. This October, we're standing with the patients, survivors, caregivers, and researchers working toward earlier answers. Get screened, know your baseline, and support the science. 🎗️
BCR::ABL1 monitoring shouldn't mean choosing precision, sensitivity, or coverage.
📄 Linear across 6 logs, CVs ≤2.6%
🧬 4 transcripts linear 10%→0.0032%
🎯 Near-zero background (20 negatives, 0-1 counts)
Free app note: na2.hubs.ly/H081qfN0
Digital PCR has moved from promising to proven. Proud to sponsor this @GenomeWeb webinar with Wim Trypsteen (University of Ghent) and our own Gordon Janaway, PhD. Oct 28, 11am ET.
Register: na2.hubs.ly/H07Sr5M0
Today's the day. Introducing Ancora: the new standard in molecular testing. More targets, more range, more certainty, all from a single reaction. Direct single-molecule counting. Fusion + co-mutation resolution. Results in as little as 3 hours. Learn more: na2.hubs.ly/H07_9Xx0
MRD monitoring in leukemia forces a compromise: broad coverage or sensitivity, rarely both. That's changing, and Thursday's webinar is only part of what we've got planned.
Don't miss it: na2.hubs.ly/H07Qs0m0
Countable Labs is proud to sponsor @tech_networks Advances in Drug Discovery & Development 2026.
This online symposium explores how AI, computational methods, and emerging technologies like CAR-T are reshaping drug discovery and development.
Join us: na2.hubs.ly/H07Qr-K0


























